Emergent BioSolutions Inc. (EBS) — Gross Profit

Annual figures by fiscal year, from SEC filings.

2020: $925.20M2021: $891.30M2022: $383.00M2023: $317.60M$317.60M
2020Gross Profit (USD)2023
Fiscal YearGross ProfitChange YoY
2023$317.60M-17.1%
2022$383.00M-57.0%
2021$891.30M-3.7%
2020$925.20M